Skip to Content

BioPharma Strategy Blog

Pharmacision and MichBio Team Up to Provide Biopartnering Services at Upcoming Bio International Convention in Washington DC

Many companies, especially emerging ones, don’t have the resources to attend every licensing/business development and partnering meeting.  MichBio has teamed up with  Preferred Provider, Pharmacision, to launch a FREE  biopartnering service for MichBio member companies at the upcoming BIO Business Forum during the 2011 BIO International Convention in Washington, DC on June 27-30.  MichBio and Pharmacision are ready to represent your comp

The Payoff of Strategic Early-Stage Forecasting - Pharmacision Featured in the August 2010 Issue of PM360

Using analogs and rules of thumb may give you a gut feel for market potential but provides no real value when making new product planning decisions.  Here are three essesntial elements for strategic early-stage forecasting.

As featured in the August 2010 issue of PM360, http://www.pm360online.com/f3_0810.

50% Discounts on Pharma, Biotech, and Healthcare Market Reports for the Month of October

Now Offering 50% Discounts on Business Insights Limited* Pharma, Biotech and Healthcare Market Reports and $250 For Single Data Point Queries throughout the month of October.  Learn More.
 
When exploring new markets and seeking topline updates on recent market trends, syndicated market reports are a great place to get started for an orientation and a Telescope view. 

Why Your Opinion Although Interesting, Is Irrelevant When it Comes to Commercializing New Drugs

I recently came across a book entitled, Tuned In – Uncover the Extraordinary Opportunities That Lead to Business Breakthroughs, by Craig Stull, Phil Myers & David Meerman Scott. The authors talk about a Tuned In process for developing new products that resonate with target customers. As part of the process, they have a saying that they repeat multiple times throughout the book, &

Welcome to Pharmacision and Rapid Insights

Thanks for reading and I hope the Biopharma Strategy Blog provides ideas and some new insights as you evaluate business development and licensing opportunities or develop commercialization strategies for your lead compounds or biologicals in development.  If you have any suggestions or ideas for future articles or blog topics, please send me an email at tmarten@pharmacision.com.

Syndicate content